quinazolines has been researched along with Weight Gain in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emser, A; Gallwitz, B; Rosenstock, J; von Eynatten, M; Woerle, HJ | 1 |
| Chen, D; Jiang, DF; Li, WT; Sun, C; Yang, HL; Zhang, ZZ | 1 |
| Bajaj, M; Gilman, R; Kempthorne-Rawson, J; Lewis-D'Agostino, D; Patel, S; Woerle, HJ | 1 |
| Bhattacharya, S; Gong, Y; Park, SW; Patel, S; Pinnetti, S; Seck, T; Sheu, WH; Woerle, HJ | 1 |
| Chae, S; Han, MD; Kim, SJ; Lee, S; Lee, SJ; Mar, W; Nam, KW | 1 |
| Bak, EJ; Cha, JH; Kim, JM; Park, HG; Yoo, YJ | 1 |
| Beck-Nielsen, H; Byrjalsen, I; Christiansen, C; Gram, J; Hansen, G; Henriksen, K; Karsdal, MA; Perrild, H; Qvist, P; Riis, BJ; Svendsen, OL | 1 |
| Scheen, AJ | 1 |
| Elrod, S; Harrington, C; McLaughlin-Middlekauff, J; Singh-Franco, D | 1 |
| Jarvie, BD; Leslie, KE; McKnight, DR; Peregrine, AS; Sharpe, PH; Todd, CG; Trotz-Williams, LA; Wallace, MM | 1 |
| Ernst, RA; Kratzer, FH; Kuhl, HJ; Vohra, P | 1 |
| Bartov, I; Granot, I; Hurwitz, S; Pines, M; Plavnik, I; Wax, E | 1 |
| Daniels, H; Halvorson, JC; Hoffbeck, SL; Noll, SL; Waibel, PE | 1 |
| Cabel, MC; Waldroup, PW | 1 |
| Cabel, MC; Norton, RA; Waldroup, PW; Yazwinski, TA | 1 |
| Fukuta, S; Itagaki, T; Kusukawa, R; Toma, Y; Umemoto, S; Yamakawa, K; Yoshinaga, T | 1 |
1 review(s) available for quinazolines and Weight Gain
| Article | Year |
|---|---|
DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials.
Topics: Adamantane; Clinical Trials as Topic; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Linagliptin; Male; Metformin; Nitriles; Piperidines; Purines; Pyrazines; Pyrrolidines; Quinazolines; Sitagliptin Phosphate; Triazoles; Uracil; Vildagliptin; Weight Gain | 2012 |
5 trial(s) available for quinazolines and Weight Gain
| Article | Year |
|---|---|
Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA₁c < 7% with no hypoglycaemia and no weight gain over 2 years.
Topics: Analysis of Variance; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Linagliptin; Male; Middle Aged; Purines; Quinazolines; Sulfonylurea Compounds; Treatment Outcome; Weight Gain | 2013 |
Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Linagliptin; Male; Metformin; Middle Aged; Pioglitazone; Purines; Quinazolines; Thiazolidinediones; Treatment Failure; Treatment Outcome; Weight Gain | 2014 |
Linagliptin improves glycemic control after 1 year as add-on therapy to basal insulin in Asian patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Asian People; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Linagliptin; Male; Middle Aged; Purines; Quinazolines; Treatment Outcome; Weight Gain | 2015 |
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy.
Topics: Aged; Blood Glucose; Body Composition; Bone Density; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pioglitazone; PPAR gamma; Quinazolines; Thiazolidinediones; Water-Electrolyte Balance; Weight Gain | 2011 |
Effect of halofuginone lactate on the occurrence of Cryptosporidium parvum and growth of neonatal dairy calves.
Topics: Animals; Animals, Newborn; Cattle; Cattle Diseases; Coccidiostats; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Feces; Male; Placebos; Quinazolines; Quinazolinones; Weaning; Weight Gain | 2005 |
10 other study(ies) available for quinazolines and Weight Gain
| Article | Year |
|---|---|
Long-term effects of evodiamine on expressions of lipogenesis and lipolysis genes in mouse adipose and liver tissues.
Topics: Adipose Tissue; Animals; Body Temperature; Diet; Dose-Response Relationship, Drug; Drug Administration Schedule; Gene Expression Regulation; Lipogenesis; Lipolysis; Liver; Male; Mice; Quinazolines; Weight Gain | 2014 |
Rutecarpine ameliorates bodyweight gain through the inhibition of orexigenic neuropeptides NPY and AgRP in mice.
Topics: Agouti-Related Protein; Animals; Cell Line; Down-Regulation; Eating; Hypothalamus; Indole Alkaloids; Mice; Mice, Inbred C57BL; Neurons; Neuropeptide Y; Obesity; Promoter Regions, Genetic; Quinazolines; Weight Gain | 2009 |
Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes.
Topics: Adipocytes; Adiponectin; Adipose Tissue; Animals; Blood Glucose; Cell Differentiation; Cell Line; Dietary Fats; Drug Therapy, Combination; Hypoglycemic Agents; Insulin; Liver; Mice; Mice, Inbred C57BL; Obesity; Plant Extracts; Quinazolines; Rosiglitazone; Thiazolidinediones; Weight Gain | 2010 |
Response letter. Effects of linagliptin.
Topics: Blood Glucose; Dipeptidyl-Peptidase IV Inhibitors; Fasting; Humans; Hypoglycemic Agents; Linagliptin; Metformin; Postprandial Period; Purines; Quinazolines; Respiratory System; Weight Gain; Weight Loss | 2012 |
Effect of halofuginone (Stenorol) on Chukar partridge (Alectoris chukar).
Topics: Animals; Coccidiostats; Dose-Response Relationship, Drug; Feeding Behavior; Growth; Piperidines; Poultry; Quinazolines; Quinazolinones; Weight Gain | 1996 |
Increased skin tearing in broilers and reduced collagen synthesis in skin in vivo and in vitro in response to the coccidiostat halofuginone.
Topics: Animals; Cells, Cultured; Chickens; Coccidiostats; Collagen; Dose-Response Relationship, Drug; Female; Fibroblasts; Monensin; Nicarbazin; Piperidines; Quinazolines; Quinazolinones; Random Allocation; Skin; Weight Gain | 1991 |
Influence of virginiamycin on growth and efficiency of large white turkeys.
Topics: Amebicides; Amprolium; Animal Feed; Animals; Arsanilic Acid; Drug Interactions; Eating; Energy Metabolism; Female; Male; Monensin; Mortality; Piperidines; Quinazolines; Quinazolinones; Sex Characteristics; Turkeys; Virginiamycin; Weight Gain | 1991 |
Effects of different coccidiostats on performance of large white turkeys.
Topics: Amprolium; Animal Feed; Animals; Coccidiostats; Dietary Fats; Dinitolmide; Eating; Female; Male; Monensin; Organotin Compounds; Piperidines; Pyrimidines; Quinazolines; Quinazolinones; Random Allocation; Sulfadimethoxine; Turkeys; Weight Gain | 1991 |
Efficacy of different anticoccidials against experimental coccidiosis in large white turkeys.
Topics: Amprolium; Animals; Coccidiosis; Coccidiostats; Dinitolmide; Feces; Intestines; Male; Monensin; Organotin Compounds; Piperidines; Poultry Diseases; Pyrimidines; Quinazolines; Quinazolinones; Sulfadimethoxine; Turkeys; Weight Gain | 1991 |
Hemodynamic benefits of long-term bunazosin (alpha-1 blocker) therapy in rats with myocardial infarction and heart failure.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiac Output, Low; Chronic Disease; Female; Heart Ventricles; Hemodynamics; Myocardial Infarction; Quinazolines; Rats; Rats, Inbred Strains; Vascular Resistance; Weight Gain | 1989 |